| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.058 | 0.04 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.04 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.04 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |